SCHEMBL16592647

SCHEMBL16592647

N#Cc1ccc(S(=O)(=O)Nc2ccc(F)cc2F)cc1

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ATIC P31939 1/20 0.56
SLC22A12 Q96S37 1/20 0.55
LMNA P02545 1/20 0.55
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
KEAP1 Q14145 1/20 0.49
NFE2L2 Q16236 1/20 0.49
MOGAT2 Q3SYC2 2/20 0.48
HSD11B1 P28845 2/20 0.48
THRB P10828 1/20 0.48
ACLY P53396 1/20 0.47
GLO1 Q04760 1/20 0.47
MAPT P10636 1/20 0.46
IDO1 P14902 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7595509 0.90 SLC22A12 (0.56) ATICSLC22A12MEN1KMT2AKEAP1
SCHEMBL21999843 0.82 ACLY (0.65) SLC22A12LMNAMEN1KMT2AMOGAT2
SCHEMBL9209669 0.80 LMNA (0.58) LMNAMEN1KMT2AKEAP1NFE2L2
SCHEMBL5801171 0.80 LMNA (0.61) LMNAMEN1KMT2AKEAP1NFE2L2
SCHEMBL24697641 0.78 MOGAT2 (0.44) ATICSLC22A12LMNAKMT2AMOGAT2
SCHEMBL31086082 0.78 MOGAT2 (0.44) ATICSLC22A12LMNAKMT2AMOGAT2
SCHEMBL76535 0.78 CYP2D6 (0.60) LMNAMEN1KMT2AKEAP1NFE2L2
SCHEMBL7596259 0.77 CCR2 (0.50) SLC22A12ACLY
SCHEMBL851450 0.77 SLC22A12 (0.54) SLC22A12MEN1KMT2AACLY
SCHEMBL1818184 0.77 METAP2 (0.62) LMNAMEN1KMT2AMOGAT2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2853532-B1 1,2,4-oxadiazole derivatives as allosteric modulators of metabotropic glutamate receptors belonging to group III INST FARMAKOLOGII POLSKIEJ AKADEMII NAUK (PL) 2020-12-09 EP disclosed
EP-2853532-A1 1,2,4-oxadiazole derivatives as allosteric modulators of metabotropic glutamate receptors belonging to group III Instytut Farmakologii Polskiej Akademii Nauk (PL) 2015-04-01 EP disclosed